EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Astragaloside IV Attenuates High-Glucose-Induced Impairment in Diabetic Nephropathy by Increasing Klotho Expression via the NF-κB/NLRP3 Axis

Jiaxin He iD, Jialin Cui, Yimin Shi, Tao Wang iD, Junyan Xin, Yimeng Li, Xiaomeng Shan iD, Zhiyao Zhu iD, Yanbin Gao iD

Journal of Diabetes Research · 22.05.2023 · 2023 · 1-22

DOI: 10.1155/2023/7423661 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Diabetes Research, erschienen am 22.05.2023. Verfasst von Jiaxin He und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, School of Traditional Chinese Medicine, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Podocytes, Diabetes Mellitus. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Basic Research Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Deficiencies in klotho are implicated in various kidney dysfunctions including diabetic nephropathy (DN) related to inflammatory responses. Klotho is closely related to inflammatory responses and is a potential target for ameliorating kidney failure. Pyroptosis, an inflammatory form of programmed cell death, is reported to take part in DN pathogenesis recently. This study is aimed at exploring whether and how klotho inhibited podocyte pyroptosis and whether astragaloside IV (AS-IV) protect podocyte through the regulation of klotho. Materials and Methods. SD rat model of DN and conditionally immortalized mouse podocytes exposed to high glucose were treated with AS-IV. Biochemical assays and morphological examination, cell viability assay, cell transfection, phalloidin staining, ELISA, LDH release assay, SOD and MDA detection, MMP assay, ROS level detection, flow cytometry analysis, TUNEL staining assay, PI/Hoechst 33342 staining, immunofluorescence assay, and western blot were performed to elucidate podocyte pyroptosis and to observe the renal morphology.

Results

The treatment of AS-IV can improve renal function and protect podocytes exposed to high glucose. Klotho was decreased, and AS-IV increased klotho levels in serum and kidney tissue of DN rats as well as podocytes exposed to high glucose. AS-IV can inhibit DN glomeruli pyroptosis in vivo. In vitro, overexpressed klotho and treatment with AS-IV inhibited pyroptosis of podocytes cultured in high glucose. Klotho knockdown promoted podocyte pyroptosis, and treatment with AS-IV reversed this effect. Furthermore, the overexpression of klotho and AS-IV reduces oxidative stress levels and inhibited NF-κB activation and NLRP3-mediated podocytes’ pyroptosis which was abolished by klotho knockdown. In addition, both the ROS inhibitor NAC and the NF-κB pathway inhibitor PDTC can inhibit NLRP3 inflammasome activation. NLRP3 inhibitor MCC950 can inhibit pyroptosis of podocytes exposed to high glucose.

Conclusion

Altogether, our results demonstrate that the protective effect of AS-IV in upregulating klotho expression in diabetes-induced podocyte injury is associated with the inhibition of NLRP3-mediated pyroptosis via the NF-κB signaling pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NephropathiesPodocytesDiabetes MellitusRatsMiceAnimalsNF-kappa BNLR Family, Pyrin Domain-Containing 3 ProteinReactive Oxygen SpeciesRats, Sprague-DawleyGlucoseInflammasomesSaponinsTriterpenes

Substanzen

NF-kappa BNLR Family, Pyrin Domain-Containing 3 ProteinReactive Oxygen SpeciesGlucoseInflammasomesastragaloside ASaponinsTriterpenesNlrp3 protein, mouseNlrp3 protein, rat

Autor:innen und Institutionen

  • Department of Endocrinology, School of Traditional Chinese Medicine, Capital Medical University, Beijing, China.
  • Department of Endocrinology, Beijing Key Laboratory of Traditional Chinese Medicine Collateral Disease Theory Research, Beijing, China.

ORCID-Profile: Jiaxin He, Tao Wang, Xiaomeng Shan, Zhiyao Zhu, Yanbin Gao

Förderung

  • National Basic Research Program of China

Zitieren

APA

He, J., Cui, J., Shi, Y., Wang, T., Xin, J., Li, Y., Shan, X., Zhu, Z., & Gao, Y. (2023). Astragaloside IV Attenuates High-Glucose-Induced Impairment in Diabetic Nephropathy by Increasing Klotho Expression via the NF-κB/NLRP3 Axis. Journal of Diabetes Research, 2023, 1-22. https://doi.org/10.1155/2023/7423661

Vancouver

He J, Cui J, Shi Y, Wang T, Xin J, Li Y, et al. Astragaloside IV Attenuates High-Glucose-Induced Impairment in Diabetic Nephropathy by Increasing Klotho Expression via the NF-κB/NLRP3 Axis. Journal of Diabetes Research. 2023;2023:1-22. doi:10.1155/2023/7423661

BibTeX
@article{He2023,
  author = {He, Jiaxin and Cui, Jialin and Shi, Yimin and Wang, Tao and Xin, Junyan and Li, Yimeng and Shan, Xiaomeng and Zhu, Zhiyao and Gao, Yanbin},
  title = {Astragaloside IV Attenuates High-Glucose-Induced Impairment in Diabetic Nephropathy by Increasing Klotho Expression via the NF-κB/NLRP3 Axis},
  journal = {Journal of Diabetes Research},
  year = {2023},
  volume = {2023},
  pages = {1--22},
  doi = {10.1155/2023/7423661}
}
Kostenlos starten →